000012872 000__ 03232cam\a2200637\i\4500
000012872 001__ 12872
000012872 003__ SzGeWIPO
000012872 005__ 20210318092546.0
000012872 008__ 020709s2001\\\\nyua\\\\rb\\\u001\0\eng\d
000012872 020__ $$a0953940306
000012872 020__ $$z9780953940301
000012872 035__ $$a(wipo)(CD )02-0474
000012872 035__ $$a(OCoLC)49046688
000012872 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000012872 043__ $$ae-uk---$$ae------
000012872 050_4 $$aK1519.B54$$bW37 2001
000012872 050_4 $$aKD1387.B55$$bW37 2001
000012872 050_4 $$aKJC2751.B56$$bW37 2001x
000012872 08204 $$a346.0486$$221
000012872 08204 $$a346.410486$$221
000012872 084__ $$aG 252 WAR.P
000012872 090__ $$c13457$$d13457
000012872 1001_ $$aWarren-jones, Amanda,$$eauthor.
000012872 24510 $$aPatenting rDNA :$$bhuman and animal biotechnology in the United Kingdom and Europe /$$cAmanda Warren-Jones.
000012872 264_1 $$aWitney, Oxon [England] :$$bLawtext Pub.,$$c2001.
000012872 300__ $$axxxi, 274 pages :$$billustrations ;$$c25 cm
000012872 336__ $$atext$$btxt$$2rdacontent
000012872 337__ $$aunmediated$$bn$$2rdamedia
000012872 338__ $$avolume$$bnc$$2rdacarrier
000012872 504__ $$aIncludes bibliographical references (pages xxii-xxix) and index.
000012872 5050_ $$aIntroduction: the science -- 1. Applications and implications -- 2. Patent law: positive aspects -- 3. Patent law: negative aspects -- 4. Morality -- 5. Legislation: harmonisation and reform.
000012872 520__ $$aThe science that underpins the recent advances in biotechnology poses a series of problems for the existing systems of intellectual property protection. A heated public debate accompanied the adoption of the European Biotech Directive. What protection should be given to the fruits of this new technology? Should ethical issues be dealt with by the patent system? How to encourage further research without at the same time discouraging competitors? These are the main themes of this debate. In this book the author reviews and analyses this debate, sets out the current legal issues and charts the development of the current practice of both the European Patent Office and how national courts have dealt with the issues of patentability, scope of protection and infringement.
000012872 650_0 $$aRecombinant DNA$$vPatents.
000012872 650_0 $$aPatent laws and legislation$$zGreat Britain.
000012872 650_0 $$aPatents$$zGreat Britain.
000012872 650_0 $$aBiotechnology$$zGreat Britain.
000012872 650_0 $$aPatents$$zUnited Kingdom.
000012872 650_0 $$aPatent infringement$$zUnited Kingdom.
000012872 650_0 $$aIntellectual property$$zUnited Kingdom.
000012872 650_4 $$aPATENTS : PATENTABILITY : BIOTECHNOLOGY : UNITED KINGDOM, EUROPE
000012872 650_4 $$aBIOTECHNOLOGY : LEGAL AND ETHICAL ASPECTS
000012872 650_4 $$aBIOPIRACY
000012872 650_4 $$aBIOMEDICINE
000012872 650_4 $$aANIMAL BIOTECHNOLOGY
000012872 650_4 $$aDNA TECHNOLOGY, GENES, GENETIC INFORMATION, CLONING
000012872 650_4 $$aHUMAN BIOTECHNOLOGY
000012872 650_6 $$aADN recombinant$$xBrevets d'invention.
000012872 650_6 $$aBrevets d'invention$$xDroit$$zGrande-Bretagne.
000012872 651_0 $$aUnited Kingdom$$xCommerce$$xLaw and legislation.
000012872 651_0 $$aEurope$$xCommerce$$xLaw and legislation.
000012872 651_0 $$aGreat Britain$$xCommerce$$xLaw and legislation.
000012872 7001_ $$aWarren-Jones, Amanda.
000012872 903__ $$v1
000012872 942__ $$cMON
000012872 952__ $$w2006-11-03$$p2002-0474$$r49.50$$u14089$$bMAIN$$10$$kG 252 WAR.P$$v2002-07-09$$zMISSING$$70
000012872 980__ $$aBIB
000012872 999__ $$c13457$$d13457